As of 2026-04-03, the Intrinsic Value of Beyond Medical Technologies Inc (DOCT.CN) is -1.06 CAD. This DOCT.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.19 CAD, the upside of Beyond Medical Technologies Inc is -660.14%.
Based on its market price of 0.19 CAD and our intrinsic valuation, Beyond Medical Technologies Inc (DOCT.CN) is overvalued by 660.14%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.06 - -1.06 | -1.06 | -660.14% |
| DDM - Stable | (0.35) - (0.72) | (0.53) | -381.6% |
| DDM - Multi | (0.20) - (0.32) | (0.24) | -228.8% |
| Market Cap (mil) | 6.17 |
| Beta | 2.45 |
| Outstanding shares (mil) | 32.49 |
| Enterprise Value (mil) | 5.27 |
| Market risk premium | 5.10% |
| Cost of Equity | 14.76% |
| Cost of Debt | 5.00% |
| WACC | 14.64% |